In adults, lead V 1 is commonly selected for arrhythmia monitoring due to its ability to help discriminate between ventricular tachycardia (VT) and aberrancy. Appropriate electrode placement and lead selection is paramount to ensure proper continuous rhythm monitoring.The goal of continuous ECG monitoring is to aid in: (a) immediate recognition of sudden cardiac arrest to improve time to defibrillation (b) recognize deteriorating conditions such as early after-depolarizations or nonsustained arrhythmias that may lead to a life-threatening arrhythmia (c) facilitate management of arrhythmias and (d) diagnose arrhythmias or aid in identifying the cause of symptoms (such as syncope and palpitations) and help guide management. It updates the Practice Standards originally published in 2004, and addresses the overuse of monitoring the appropriate use of continuous ECG monitoring in the settings of ischemia, arrhythmia, and QT-prolongation alarm management and documentation in health records. The purpose of this Scientific Statement is to provide a comprehensive review and update for recommendations for continuous ECG monitoring of hospitalized patients.The following are key points to remember about the 2017 update to the American Heart Association (AHA) Scientific Statement on Practice Standards for Electrocardiographic (ECG) Monitoring in Hospital Settings:
0 Comments
Leave a Reply. |